Role of IL-6 in cytokine-induced sickness behavior a study with IL-6 deficient mice

[1]  R. Dantzer,et al.  Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats , 1999, Psychoneuroendocrinology.

[2]  C. Dinarello Cytokines as endogenous pyrogens. , 1999, The Journal of infectious diseases.

[3]  M. Herkenham,et al.  Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat , 1999, Journal of Neuroimmunology.

[4]  C. Plata-salamán Brain mechanisms in cytokine-induced anorexia , 1999, Psychoneuroendocrinology.

[5]  R. Dantzer,et al.  Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. , 1998, European cytokine network.

[6]  P. Mackowiak,et al.  Concepts of fever. , 1998, Archives of internal medicine.

[7]  R. Dantzer,et al.  Molecular Basis of Sickness Behavior a , 1998, Annals of the New York Academy of Sciences.

[8]  A. Dunn,et al.  Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism , 1998, Neurochemistry International.

[9]  T. Lennie Relationship of body energy status to inflammation-induced anorexia and weight loss , 1998, Physiology & Behavior.

[10]  J. Krueger,et al.  Vagotomy Blocks the Induction of Interleukin-1β (IL-1β) mRNA in the Brain of Rats in Response to Systemic IL-1β , 1998, The Journal of Neuroscience.

[11]  R. Dantzer,et al.  Brain type I but not type II IL-1 receptors mediate the effects of IL-1β on behavior in mice. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[12]  C. Dinarello,et al.  Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. , 1997, Chest.

[13]  P. Musiani,et al.  Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. , 1997, The American journal of pathology.

[14]  D. Golenbock,et al.  Characterization of proinflammatory cytokine production and CD14 expression by murine alveolar macrophage cell lines , 1997, In Vitro Cellular & Developmental Biology - Animal.

[15]  N. Rothwell,et al.  Sixteenth Gaddum Memorial Lecture December 1996. Neuroimmune interactions: the role of cytokines , 1997, British journal of pharmacology.

[16]  S. Yamamoto,et al.  Primary structure of rat CD14 and characteristics of rat CD14, cytokine, and NO synthase mRNA expression in mononuclear phagocyte system cells in response to LPS , 1997, Journal of leukocyte biology.

[17]  R. Dantzer,et al.  Central mediation of the effects of interleukin-1 on social exploration and body weight in mice , 1997, Psychoneuroendocrinology.

[18]  A. Koj Initiation of acute phase response and synthesis of cytokines. , 1996, Biochimica et biophysica acta.

[19]  R. Dantzer,et al.  Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. , 1996, Neuroreport.

[20]  C. Sweep,et al.  Acute stimulation of the hypothalamic-pituitary-adrenal axis by IL-1ß, TNFα and IL-6: A dose response study , 1996 .

[21]  V. Poli,et al.  Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice , 1996, The Journal of experimental medicine.

[22]  L. Leon,et al.  Cytokines and fever. , 1995, Neuroimmunomodulation.

[23]  F. Holsboer,et al.  Soluble interleukin‐6 (IL‐6) receptor augments central effects of IL‐6 in vivo , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  R. Dantzer,et al.  Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats , 1995, Brain Research.

[25]  N. Rothwell,et al.  Cytokines and the nervous system II: actions and mechanisms of action , 1995, Trends in Neurosciences.

[26]  N. Rothwell,et al.  Cytokines and the nervous system I: expression and recognition , 1995, Trends in Neurosciences.

[27]  R. Dantzer,et al.  Synergy between tumor necrosis factor α and interleukin-1 in the induction of sickness behavior in mice , 1994, Psychoneuroendocrinology.

[28]  R. Dantzer,et al.  Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. , 1994, Brain research. Molecular brain research.

[29]  R. Zinkernagel,et al.  Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.

[30]  G. Ciliberto,et al.  Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.

[31]  G. Strassmann,et al.  The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. , 1993, Cytokine.

[32]  J. Abrams,et al.  Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. , 1993, Endocrinology.

[33]  W. Zhong,et al.  Regulation of cytokine mRNA expression in lipopolysaccharide-stimulated human macrophages. , 1993, Archives of surgery.

[34]  M. Brouns,et al.  Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? , 1992, Brain Research.

[35]  C. Dinarello,et al.  Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells , 1991, Brain Research.

[36]  N. Rothwell,et al.  Interleukin-6 is a centrally acting endogenous pyrogen in the rat. , 1991, Canadian journal of physiology and pharmacology.

[37]  P. Ghezzi,et al.  Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. , 1990, The Journal of infectious diseases.

[38]  A. Waage,et al.  Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo , 1989 .

[39]  S. Rosenberg,et al.  IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans. , 1989, Journal of immunology.

[40]  H. Baumann,et al.  IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. , 1989, Journal of immunology.

[41]  B. Hazenberg,et al.  The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. , 1988, Biochemical and biophysical research communications.

[42]  P. Sehgal,et al.  Induction of β 2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation , 1986, Cell.

[43]  B. Beutler,et al.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1 , 1986, The Journal of experimental medicine.

[44]  R. Dantzer,et al.  Mechanisms of the behavioural effects of cytokines. , 1999, Advances in experimental medicine and biology.

[45]  V. Poli IL-6 Unique Functions in Inflammation, Bone Metabolism, and B-Cell Neoplasias Revealed by Studies on IL-6-Deficient Mice , 1998 .

[46]  R. Dantzer,et al.  Cytokine Actions on Behavior , 1996 .

[47]  T. Bártfai,et al.  Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. , 1993, Brain research.

[48]  R. Dantzer,et al.  Sickness behavior as a new target for drug development. , 1992, Trends in pharmacological sciences.

[49]  R. Dantzer,et al.  Interleukin-1 receptor antagonist blocks effects of IL-1α and IL-1β on social behaviour and body weight in mice , 1991 .

[50]  J. Dayer,et al.  Modulation of IL-1 inflammatory and immunomodulatory properties by IL-6. , 1991, European cytokine network.

[51]  R. Nordan,et al.  Comparison of in vivo effects of human recombinant IL 1 and human recombinant IL 6 in mice. , 1988, Lymphokine research.

[52]  C. Saper,et al.  Regional induction of tumor necrosis factor ar expression in the mouse brain after systemic lipopolysaccharide administration , 2022 .